Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV13 and Fluad Concomitant Vaccination in Adults ≥60 Years
NCT02215863Phase 4Completed
- Sponsor
- Korea University Guro Hospital
- Start
- Sep 2014
- Primary completion
- Mar 2015
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of pneumococcal 13-valent conjugate vaccine, Fluzone Trivalent in influenza, pneumococcal infection, sponsored by Korea University Guro Hospital. Started Sep 2014; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccineFluzone Trivalent
03
Conditions
influenzapneumococcal infection
Beyond the preview
Go deeper on NCT02215863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02215863.